Johnson & Johnson

NYSE: JNJ
$154.00
+$2.13 (+1.4%)
Closing Price on November 15, 2024

JNJ Articles

A stock market that sells off eight of nine days is not a good market.  Even the Facebook IPO is being viewed as a one-off item rather than a systemic item which will make the market stronger. ...
Coalition talks in Greece have broken down and are not likely to resume. This means new elections are almost inevitable. That will delay the ability of the European Union and IMF to know what the...
Avon Products (NYSE: AVP) said it will take a week to decide whether it will negotiate a new, sweetened deal from Coty. Coty has just gotten financial support from Warren Buffett’s Berkshire...
Blame whatever you want.  A weaker U.S. economy, a weakening and flailing Europe, a move to socialism in France and Greece, a weaker BRIC and emerging market story, commodity prices and on and...
The government of Spain got lucky. It planned to raise over 2 billion euros in debt. The amount sold was more than that — 2.5 billion. The international capital markets ignored Spain’s high...
This was a huge week in dividends, particularly for the key DJIA components.  We had a report calling for more and more dividend hikes of about 8% from the DJIA components in 2012.  As it turns...
Consumer goods giant Procter & Gamble Co. (NYSE: PG) reported third fiscal quarter results this morning that were about in-line with expectations, but the company’s lowered full-year forecast...
How many DJIA components can raise their dividend in one week?  Johnson & Johnson (NYSE: JNJ) answered that question as “Who knows, but we can make it one more!”  J&J has joined the...
Dividends have continued to rise.  Better yet, they are expected to keep rising for the rest of the year.  A study from Dow Jones Indexes showed a rise of almost 2.2% so far this year from the 30...
The data is from a major union, and, therefore, may have a bias against chief executives. Numbers can be bent. The AFL-CIO reports that CEO pay rose 14% last year: According to data released by the...
Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B) will be in the news quite a bit now that the world’s most famous investor, chairman Warren Buffett, has been diagnosed with prostate cancer. We...
Citigroup (NYSE: C) losses an investor vote on executive compensation. (Reuters) Many experts say Spain cannot avoid a bailout. (Reuters) Nestle is close to a deal to buy Pfizer’s (NYSE: PFE) baby...
Markets opened higher this morning and by late-morning equities were trading down about 1.5% across the board, where they have mostly remained for the rest of the day. An upbeat auction on short-term...
Last week may have been the official start of earnings season, but this week is when the real floodgates for earnings reports will open wide.  Citigroup Inc. (NYSE: C) has already reported earnings...
Earnings season may be underway, but this coming week is going to be full of many key earnings reports.  We actually have a full slate on deck with what appears to be 13 of the 30 DJIA components...